Clinical trials: Histone Deacetylase (HDAC) Activity
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides
The main objective of this clinical trial is to study the efficacy and safety of cobomarsen (also known as MRG-106) for the treatment of cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF) subtype.
- Trial name
- SOLAR (NCT03713320)
- Testing
- Cobomarsen, Vorinostat
- Where
- 43 sites in United States, Australia and 6 more
- Volunteers
- 37 people
- Sponsor
- miRagen Therapeutics, Inc.